Integrated MRI-RT platforms offer precise and effective visualization of patient’s anatomical and physiological changes; that results in greater procedural accuracy and improved therapeutic outcome
0 Comments Click here to read/write comments
Topics: Medical Devices, Radiotherapy Market, MRI-RT Systems
On Dec 13, 2018 AstraZeneca, a global research based biopharmaceutical company, partnered with Guardant Health (US) for the development of CDx tests to commercialize AstraZeneca’s oncology portfolio including Tagrisso and Imfinzi. The CDx test is based on liquid biopsy platform supported by Guardant’s proprietary Digital Sequencing technology.
0 Comments Click here to read/write comments
Topics: Medical Devices, blood-based companion diagnostics, cancer therapies, liquid biopsy, healthcare, tumor mutational burden
